Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 2
1985 1
1987 2
1988 1
1989 1
1991 1
1992 5
1993 1
1994 2
1995 2
1996 1
1998 2
1999 3
2001 1
2002 3
2003 4
2004 2
2005 2
2006 2
2007 2
2008 1
2009 2
2011 1
2013 1
2014 3
2015 3
2016 2
2017 1
2018 3
2019 3
2020 3
2021 3
2022 1
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Dopamine beta-hydroxylase deficiency.
Senard JM, Rouet P. Senard JM, et al. Among authors: rouet p. Orphanet J Rare Dis. 2006 Mar 30;1:7. doi: 10.1186/1750-1172-1-7. Orphanet J Rare Dis. 2006. PMID: 16722595 Free PMC article. Review.
Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failure.
Barutaut M, Fournier P, Peacock WF, Evaristi MF, Caubère C, Turkieh A, Desmoulin F, Eurlings LWM, van Wijk S, Rocca HB, Butler J, Koukoui F, Dambrin C, Mazeres S, Le Page S, Delmas C, Galinier M, Jung C, Smih F, Rouet P. Barutaut M, et al. Among authors: rouet p. Int J Cardiol. 2020 Feb 1;300:245-251. doi: 10.1016/j.ijcard.2019.09.032. Epub 2019 Nov 18. Int J Cardiol. 2020. PMID: 31806281 Clinical Trial.
Colloidal chemistry with patchy silica nanoparticles.
Rouet PE, Chomette C, Adumeau L, Duguet E, Ravaine S. Rouet PE, et al. Beilstein J Nanotechnol. 2018 Dec 6;9:2989-2998. doi: 10.3762/bjnano.9.278. eCollection 2018. Beilstein J Nanotechnol. 2018. PMID: 30591847 Free PMC article.
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF.
Ferreira JP, Verdonschot J, Wang P, Pizard A, Collier T, Ahmed FZ, Brunner-La-Rocca HP, Clark AL, Cosmi F, Cuthbert J, Díez J, Edelmann F, Girerd N, González A, Grojean S, Hazebroek M, Khan J, Latini R, Mamas MA, Mariottoni B, Mujaj B, Pellicori P, Petutschnigg J, Pieske B, Rossignol P, Rouet P, Staessen JA, Cleland JGF, Heymans S, Zannad F; HOMAGE (Heart Omics in AGEing) Consortium. Ferreira JP, et al. Among authors: rouet p. JACC Heart Fail. 2021 Apr;9(4):268-277. doi: 10.1016/j.jchf.2020.11.010. Epub 2021 Feb 3. JACC Heart Fail. 2021. PMID: 33549556 Free article. Clinical Trial.
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial.
Ferreira JP, Collier T, Clark AL, Mamas MA, Rocca HB, Heymans S, González A, Ahmed FZ, Petutschnigg J, Mujaj B, Cuthbert J, Rouet P, Pellicori P, Mariottoni B, Cosmi F, Edelmann F, Thijs L, Staessen JA, Hazebroek M, Verdonschot J, Rossignol P, Girerd N, Cleland JG, Zannad F. Ferreira JP, et al. Among authors: rouet p. Eur Heart J Cardiovasc Pharmacother. 2022 Feb 16;8(2):149-156. doi: 10.1093/ehjcvp/pvab031. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 33822033 Free article. Clinical Trial.
The association of catestatin and endocan with the effects of cardiac shock wave therapy: Biomarker sub-study of the randomized, sham procedure-controlled trial.
Burneikaitė G, Shkolnik E, Puronaitė R, Zuozienė G, Petrauskienė B, Misonis N, Kazėnaitė E, Laucevičius A, Smih F, Rouet P, Čelutkienė J. Burneikaitė G, et al. Among authors: rouet p. Front Cardiovasc Med. 2023 Feb 23;10:1004574. doi: 10.3389/fcvm.2023.1004574. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36910537 Free PMC article.
sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure.
Barutaut M, Fournier P, Peacock WF, Evaristi MF, Dambrin C, Caubère C, Koukoui F, Galinier M, Smih F, Rouet P. Barutaut M, et al. Among authors: rouet p. Acta Cardiol. 2020 Dec;75(8):739-747. doi: 10.1080/00015385.2019.1669847. Epub 2019 Sep 27. Acta Cardiol. 2020. PMID: 31560863
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.
Cleland JGF, Ferreira JP, Mariottoni B, Pellicori P, Cuthbert J, Verdonschot JAJ, Petutschnigg J, Ahmed FZ, Cosmi F, Brunner La Rocca HP, Mamas MA, Clark AL, Edelmann F, Pieske B, Khan J, McDonald K, Rouet P, Staessen JA, Mujaj B, González A, Diez J, Hazebroek M, Heymans S, Latini R, Grojean S, Pizard A, Girerd N, Rossignol P, Collier TJ, Zannad F; HOMAGE Trial Committees and Investigators. Cleland JGF, et al. Among authors: rouet p. Eur Heart J. 2021 Feb 11;42(6):684-696. doi: 10.1093/eurheartj/ehaa758. Eur Heart J. 2021. PMID: 33215209 Free PMC article. Clinical Trial.
66 results